Cite
HARVARD Citation
Hosseini, M. et al. (2018). Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes. Leukemia. 32 (11), pp. 2374-2387. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hosseini, M. et al. (2018). Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes. Leukemia. 32 (11), pp. 2374-2387. [Online].